The PE Ratio as of December 2025 (TTM) for Kalaris Therapeutics Inc (KLRS) is -0.16

According to Kalaris Therapeutics Inc’s latest financial reports and current stock price. The company's current PE Ratio is -0.16. This represents a change of -86.66% compared to the average of -1.20 of the last 4 quarters.

Kalaris Therapeutics Inc (KLRS) Historical PE Ratio (quarterly & annually)

How has KLRS PE Ratio performed in the past?

The mean historical PE Ratio of Kalaris Therapeutics Inc over the last ten years is -2.06. The current -0.16 PE Ratio has changed 678.29% with respect to the historical average. Over the past ten years (40 quarters), KLRS's PE Ratio was at its highest in in the September 2024 quarter at -0.08. The PE Ratio was at its lowest in in the March 2019 quarter at -2.56.

Kalaris Therapeutics Inc (KLRS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kalaris Therapeutics Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kalaris Therapeutics Inc (KLRS) Average PE Ratio

How has KLRS PE Ratio performed in the past?

The current PE Ratio of Kalaris Therapeutics Inc (KLRS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kalaris Therapeutics Inc (KLRS) PE Ratio vs. Peers

How is KLRS’s PE Ratio compared to its peers?

Kalaris Therapeutics Inc’s PE Ratio is greater than InflaRx N.V. (-1.41), greater than ImageneBio Inc (-10.64), greater than Connect Biopharma Holdings Limited (-3.90), greater than Shattuck Labs, Inc. (-3.91), greater than Sutro Biopharma, Inc. (-0.37), greater than Artiva Biotherapeutics, Inc. (-1.28), greater than Metagenomi, Inc. Common Stock (-0.76), greater than Context Therapeutics Inc. (-2.87), greater than Quince Therapeutics, Inc. (-3.43), less than Ovid Therapeutics Inc. (-0.06),

Build a custom stock screener for Kalaris Therapeutics Inc (KLRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kalaris Therapeutics Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kalaris Therapeutics Inc (KLRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kalaris Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.